Johnson & Johnson launches presbyopia-correcting Tecnis Odyssey IOL in Europe

News
Article

The Tecnis Odyssey, launched in the US in October 2024, is now available in Europe, the Middle East and Canada

A map or globe, with Europe emphasised under a magnifying glass. Concept image for European launch of Johnson and Johnson presbyopia-correcting Tecnis Odyssey IOL. Image credit: ©Pakawadee – stock.adobe.com

The Tecnis Odyssey and Tecnis PureSee IOLs are now both available in Europe, the Middle East, Japan and Canada. Image credit: ©Pakawadee – stock.adobe.com

Johnson & Johnson announced it has launched the Tecnis Odyssey IOL in Europe, the Middle East, and Canada. The Tecnis Odyssey IOL was first launched in the US in October 2024.1,2

The Tecnis Odyssey IOL is a full vision range IOL built on the Tecnis platform which, according to Johnson & Johnson,1 provides two times better contrast in low lighting than PanOptix. The Tecnis Odyssey combines advanced optics and proprietary materials, offering consistently clear, high-contrast vision, according to the company.

Peter Menziuso, company group chairman of Vision at Johnson & Johnson, commented on the launch in a news release from the company, saying, “Tecnis Odyssey IOL is the fastest-growing PC-IOL in the United States, and we are excited to be making it available to more patients around the world. It addresses a significant unmet need for cataract patients seeking greater spectacle independence. Now—together with Tecnis PureSee—Tecnis Odyssey IOL elevates the strength and depth of our global IOL portfolio, meeting the diverse needs of today's aging population.”

Additionally, the company says that the Tecnis Odyssey and its unique freeform diffractive surface were designed to eliminate the gaps between near, intermediate and far distances, and offer continuous, uninterrupted vision at all distances. More than 95% of patients were satisfied with both reading on a smartphone/tablet and distance vision.

Johnson & Johnson’s portfolio of advanced presbyopia correcting IOLs available in Europe, the Middle East, Canada and Japan now includes both the Tecnis Odyssey IOL and the Tecnis PureSee IOL.

References:

  1. Johnson & Johnson launches new TECNIS Odyssey next-generation intraocular lens in Europe, the Middle East, and Canada offering cataract patients precise vision at every distance in any lighting. June 17, 2025. Accessed June 17, 2025. https://www.prnewswire.com/news-releases/johnson--johnson-launches-new-tecnis-odyssey-next-generation-intraocular-lens-in-europe-the-middle-east-and-canada-offering-cataract-patients-precise-vision-at-every-distance-in-any-lighting1-6--302483215.html
  2. Harp MD. Johnson & Johnson launches TECNIS Odyssey IOL in US. October 1, 2024. Accessed June 17, 2025. https://www.ophthalmologytimes.com/view/johnson-johnson-launches-tecnis-odyssey-iol-in-us

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.